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Abstract
Purpose. Strains of type emm89 Streptococcus pyogenes have recently increased in frequency as a cause of human
infections in several countries in Europe and North America. This increase has been molecular epidemiologically linked with
the emergence of a new genetically distinct clone, designated clade 3. We sought to extend our understanding of this
epidemic behavior by the genetic characterization of type emm89 strains responsible in recent years for an increased
frequency of infections in Scotland.
Methodology. We sequenced the genomes of a retrospective cohort of 122 emm89 strains recovered from patients with
invasive and noninvasive infections throughout Scotland during 2010 to 2016.
Results. All but one of the 122 emm89 infection isolates are of the recently emerged epidemic clade 3 clonal lineage. The
Scotland isolates are closely related to and not genetically distinct from recent emm89 strains from England, they constitute
a single genetic population.
Conclusions. The clade 3 clone causes virtually all-contemporary emm89 infections in Scotland. These findings add Scotland
to a growing list of countries of Europe and North America where, by whole genome sequencing, emm89 clade 3 strains
have been demonstrated to be the cause of an ongoing epidemic of invasive infections and to be genetically related due to
descent from a recent common progenitor.
INTRODUCTION
Streptococcus pyogenes, a strict human pathogen, causes
highly diverse infections that range in severity from com-
mon self-limiting skin and throat infections (impetigo and
pharyngitis), to less common invasive infections that have
high morbidity and mortality such as scarlet fever, sepsis
and necrotizing fasciitis [1]. For decades, S. pyogenes strains
were subtyped based on serologic diversity in the M protein,
a highly polymorphic surface-displayed molecule that is an
important virulence factor involved in multiple host–
pathogen interactions, including adherence and resistance
to phagocytosis [2]. Over the last 20 years, a shift away from
M protein serotyping to emm gene sequence typing has
occurred. Greater than 220 distinct emm types have been
described based on allelic variation in the region of the emm
gene that encodes the highly polymorphic amino terminal
50 amino acids of the mature M protein [3].
Considerable new information has been obtained by emm
gene sequence typing. However, whole genome sequence
analysis of approximately 10 000 S. pyogenes strains [4–15]
has revealed that polymorphisms exist among strains classi-
fied by emm type and found that the genome of nearly every
strain is genetically distinct. The largest contributors to this
genome-to-genome variation are mobile genetic elements
(MGE), such as prophages and integrative conjugative ele-
ments (ICE), and small sequence differences such as single
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nucleotide polymorphisms (SNPs) and short insertions and
deletions (indels). The genome sequence data provide a rich
source of information for epidemiologic and pathogenesis
studies framed within an evolutionary population genomic
context.
In recent years, strains of emm89 S. pyogenes have been
reported as a cause of increasing disease frequency in many
countries worldwide, and have been documented to be a
cause of local disease outbreaks [6, 15–43]. Genome
sequence analysis of almost 1500 emm89 strains from the
USA, Finland, Iceland, Canada (Ontario), the UK (the great
majority from England) and Portugal has identified three
major genetically distinct strain clusters, designated clades
1, 2 and 3 [6, 14, 15, 19, 24, 41]. Clade 1 strains have been
identified only in the USA and Canada. Importantly, con-
current with a significant increase in the number and fre-
quency of invasive emm89 infections, clade 3 strains
emerged in the early 2000s and around 2007–2009
expanded rapidly in the USA, Finland and Iceland, displac-
ing their predecessor clade 1 and 2 strains in these countries
[6, 41]. Similarly, clade 3 organisms have become abundant
in England, where they also displaced clade 2 organisms
[15]. The emm89 clades differ predominantly due to multi-
ple horizontal genetic transfer (HGT) events, several of
which involve known virulence factors [6, 15]. Moreover,
whole genome RNAseq expression analysis found that these
regions of recombination were significantly non-randomly
associated with altered gene expression [6].
The goal of the present study was to analyse the genome
sequences of all available emm89 strains causing infections
in Scotland between 2010 and 2016. We also sought to
determine if geographic and temporal variation occurred in
the genomic types of organisms causing disease in the coun-
try. Here we report that with a single exception, recently
emergent clade 3 strains caused all invasive emm89 infec-
tions in Scotland during the study period. There is restricted
evidence of genetic substructure of emm89 clade 3 subclones
within Scotland and other regions of the UK.
METHODS
Bacterial strains
The 122 emm89 strains newly sequenced and studied herein
were cultured from individuals throughout Scotland
between 2010 and 2016, including 98 from patients with
symptomatic infections at normally sterile sites (designated
invasive infection isolates). Strains were identified as
emm89 by emm gene sequencing as described [44], and con-
firmed to be emm89 based on whole genome sequence data
(see below). The strain sample includes virtually all emm89
organisms causing invasive infections in Scotland from
2013 onward. The strain samples from 2010 through 2012
were largely from Glasgow and Lanarkshire, that is, the west
central belt of Scotland (Fig. S1, available in the online ver-
sion of this article). The sample also included 24 strains cul-
tured from throats of individuals with pharyngitis
or asymptomatic colonization (designated non-invasive
infection isolates). The strain, year, infection type, geo-
graphic location and phage-profile are presented in
Table S1.
For the purpose of epidemiologic and genetic comparisons,
genome data from 133 previously sequenced emm89 S. pyo-
genes strains [6, 15, 41] were also used in this investigation,
and are referenced at the appropriate places below.
Multiplexed genome sequencing
Bacterial cells were lysed with mutanolysin and lysozyme
(Sigma, St. Louis, MO) and chromosomal DNA was
extracted with the DNeasy 96 Blood and Tissue Kit (Qiagen,
Germantown, MD). The extracted DNA was quantified
with a Qubit 3 Fluorometer using a Qubit dsDNA BR Assay
Kit (Invitrogen, Carlsbad, CA). Sequencing libraries were
generated by tagmentation from the extracted DNA with
the Nextera XT DNA Sample Preparation Kit and Index Kit
V2 (Illumina, San Diego, CA). The DNA concentration of
the resultant individual index tagged libraries was measured
with a Qubit dsDNA HS Assay Kit. The DNA size distribu-
tion (quality) of a random subset of the libraries (approxi-
mately 5%), was assessed with a Bioanalyzer instrument
using a HS DNA Kit (Agilent, Santa Clara, CA). Libraries in
sets of 96 samples were pooled at equivalent concentrations,
and paired-end 150 nt sequence reads were obtained from
the pooled libraries using a NextSeq 500/550 High Output
Reagent v2 300 Cycle Cartridge and an Illumina NextSeq
instrument. Data for the 122 newly sequenced emm89
genomes were deposited in the NCBI Sequence Read
Archive under accession number PRNJNA387243.
Data preprocessing and initial genetic
characterization
Before the sequence data were used in subsequent genetic
analyses, reads were preprocessed to remove low quality
sequences and library generation artifacts (e.g. adaptor
contamination) with Trimmomatic [45], and base call
errors were corrected with Musket [46]. Reads were then
assembled de novo with SPAdes [47]. The S. pyogenes
genome is approximately 2 Mbp in length. Strains for
which the de novo assembly was larger than 2.2 Mbp were
considered potentially contaminated and were reisolated
and resequenced (n=9, 5 from the throat a non-sterile site
of isolation) or excluded (n=2, viable pure cultures were
not obtained) from further analysis. The resultant high-
quality and contaminant-free reads were used in subse-
quent genetic analyses. The multi-locus sequence type
(https://pubmlst.org/spyogenes/), emm type (ftp://ftp.cdc.
gov/pub/infectious_diseases/biotech/tsemm/), presence of
hyaluronate capsule synthesis genes (hasABC) and pres-
ence of potential antibiotic resistance genes (http://en.med-
iterranee-infection.com/article.php?laref=283%26titre=arg-
annot) were assessed using SRST2 [48] with the indicated
databases. This initial genetic typing confirmed the species
and emm type of the strains studied.
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Polymorphism discovery
Preprocessed reads were aligned to the genome of emm89
clade 2 reference strain MGAS23530 (GenBank accession
number CP013839) using SMALT (http://sourceforge.net/
projects/smalt/). Sequence differences between the aligned
reads and the reference genome were identified with Free-
Bayes [49]. These polymorphism data were filtered on the
basis of alternate base call consensus (70%), mapped
quality (Q30) and coverage depth (10-fold) using
VCFfilter (https://github.com/ekg/vcflib#vcflib). Since the
genome of strain MGAS23530 lacks prophages and integra-
tive and conjugative elements, the resultant polymorphism
calls were made relative to only the core chromosome,
thereby obviating the need to exclude phylogenetic infer-
ence potentially distorting polymorphisms within MGEs.
Phylogenetic inference and population structure
SNPs (i.e. variant site nucleotides) identified relative to the
1709394 genome of emm89 clade 2 reference strain
MGAS23530 along with all invariant site nucleotides were
concatenated in sequential order to generate entire core
genome aligned sequences for each strain studied using Pre-
phix, Phrecon and SNPswapper (https://github.com/coding-
hedgehog). Based on the 1709394 nucleotide full-length
core genome aligned sequences, regions of putative horizon-
tal transfer were predicted and polymorphisms within these
regions were removed using Gubbins [50]. To constrain the
inferences to primarily vertically inherited nucleotide differ-
ences, all phylogenetic reconstructions presented are based
on Gubbins-filtered core genome SNPs. Phylogeny among
strains was inferred by the neighbour-joining method with
SplitsTree [51], and tree figures were generated with Den-
droscope [52]. Genetic distances between strains (pairwise
and overall mean SNP differences) were determined with
MEGA [53]. Root-to-tip genetic distances were determined
using TempEst [54].
Gene content and MGE analysis
Total gene and MGE content were assessed for the strains
studied relative to the non-redundant pangenome gene con-
tent defined for 30 complete S. pyogenes genomes represent-
ing 18 emm types, as previously described, with minor
modifications [6]. Briefly, reads were mapped to the pange-
nome (denoted GAS-30) with SMALT and the mean depth
of coverage was determined with BEDTools2 [55] for all
2835 gene clusters represented. To compensate for differen-
ces in the depth of sequencing, depth-of-coverage for reads
mapped relative to genome of reference strain MGAS23530
was normalized to 100-fold. Based on mapping of the
sequencing reads from the clade 3 reference genome
MGAS27061 to the GAS-30 pangenome, a normalized
mean DOC value of >10 corresponded with gene presence
and <10 with gene absence. The resultant gene content data
were used to infer phage presence or absence, which was
expressed as prophage content profiles or prophage geno-
types as previously defined for 1193 emm89 strains [6]. A
prophage was called present if a minimum of 75 percent of
its gene content represented in the GAS-30 pangenome was
determined to be present. Reads not mapping to the GAS-
30 pangenome were assembled de novo with SPAdes. Resul-
tant contigs greater than 100 nucleotides were queried
against the NCBI non-redundant database using BLAST to
determine their nature.
RESULTS
Genome sequencing and initial analysis
The genomes of all 122 strains from individuals from
Scotland (n=98 invasive disease isolates and n=24 throat
non-invasive isolates) were sequenced to a mean 231-fold
depth-of-coverage (range, 108-fold–519-fold) using a
paired-end 150 nt read strategy, and polymorphisms were
identified. Inference of genetic relationships using core
chromosomal SNPs found that these emm89 strains from
Scotland have a major population of 121 strains, and a sin-
gle genetically divergent outlier strain (Fig. 1). Phylogenetic
analysis showed the major emm89 population of 121 strains
corresponded to previously identified epidemic clade 3,
whereas the single outlier strain (MGAS31744) was a pree-
pidemic clade 2 organism (Fig. 1).
Variation in gene content and prophage genotypes
We, and others, have shown that emm89 S. pyogenes strains
can vary in gene content as a consequence of HGT and dif-
ferences in MGE content [6, 15, 41]. The gene content (i.e.
gene presence or absence) of the 122 Scotland emm89
strains was determined relative to the pangenome con-
structed from the combined gene content (>53 000 genes)
of 30 S. pyogenes genomes of 18 emm types [6]. No ICEs
were detected in the 122 strains. Virtually all differences in
gene content are due to strain-to-strain differences in the
five prophages detected among the 122 strains (Fig. 2a).
Our analysis identified nine different prophage content
profiles or prophage genotypes (Fig. 2a). The three more
prevalent prophage genotypes are each present in 13 or
more strains and account for 109 (89.3%) of all 122 isolates
(Fig. 2b). The remaining six prophage genotypes are each
present in four or fewer strains and account for only 13
(10.7%) of the isolates. The three most prevalent prophage
genotypes (PG01, PG02 and PG04) among these Scotland
isolates are those previously identified to be prevalent
among 756 emm89 clade 3 strains in the USA and Finland
[6]. The most prevalent prophage genotype (PG01) was
found in 60 (49.1 %) of the 122 isolates. Clade 3 reference
strain MGAS27061 has prophage genotype PG01. PG01 is
characterized by the presence of one prophage (f27061.1)
encoding two virulence factors, superantigen pyrogenic
exotoxin SpeC and secreted DNase Spd1. The second most
prevalent prophage genotype (PG02), was found in 36
(29.5%) isolates, and is characterized by a lack of
prophages in the genome. Clade 2 reference strain
MGAS23530 (GenBank accession number CP013839) has
prophage genotype PG02. The third most prevalent type
(PG04), was found in 13 (10.7%) isolates, and consists of
prophage 27061.1 and a second prophage integrated into
the genome at the two-component system regulator yesMN.
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This prophage shares substantial gene content with pro-
phage 10270.3, and both encode the virulence factors’
superantigen pyrogenic exotoxin SpeK and secreted phos-
pholipase Sla (Fig. 3). The intermingling of these three pro-
phage genotypes on multiple branches of the tree is
consistent with these prophages being dynamically gained
and lost in the population (that is, the prophage genotypes
are not uniquely associated with a given genetic back-
ground). Additionally, as expected, all 121 of the Scotland
clade 3 strains lacked the hyaluronic acid capsule synthesis
genes (hasABC) consistent with previous findings [6, 15,
41, 42].
Fig. 1. Genetic relationships among the Scotland emm89 strains. The reconstructed phylogeny for 122 Scotland emm89 strains in
conjunction with emm89 clade 2 and clade 3 reference strains, MGAS23530 and MGAS27061 respectively, inferred by the neighbour-
joining method based on 1410 core chromosomal SNPs, is shown. To constrain the inference to primarily vertically inherited SNPs,
SNPs were filtered with Gubbins to exclude sites predicted to be horizontally acquired. The tree is rooted on clade 2 reference strain
MGAS23530. The mean genetic distance in nucleotide differences (i.e. SNPs strain-to-strain) among the 121 clade 3 strains is 48.1,
and between clade 2 strain MGAS31744 and the clade 3 strains as a group is 107.7.
Fig. 2. Prophage content of the Scotland emm89 strains. (a) A matrix of the five prophages and the nine different profiles of prophage
content identified among the Scotland isolates is illustrated. The three most prevalent profiles 1, 2 and 3 correspond respectively with
prophage genotypes PG01, PG02 and PG04, previously defined for 1193 emm89 strains [6]. (b) The phylogeny of the 122 Scotland
strains inferred by neighbour-joining based on 1410 core SNPs is shown. The tree is rooted on clade 2 reference strain MGAS23530.
Strains are coloured by their prohage genotype as indicated in the index. Differences in the tree among closely genetically related
strains are evident in prophage content, consistent with prophage gain and loss events.
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Genome analysis of strains cultured from throats
Twenty-four organisms cultured from the throat were stud-
ied. We found that the throat isolates were genetically inter-
mixed with the invasive isolates. That is, the throat and
invasive strains were not separate genetically distinct groups
(Fig. 4).
Genetic structure with respect to year of isolation
We examined if a distinct temporal relationship existed
between the year of strain isolation and the topology of
the phylogenetic tree. In general, isolates from the early
years of the Scotland sample tend to be located closer to
the root of the tree, whereas those recovered in the later
years (2015 and 2016) were located farther toward the
tips of the tree branches (Fig. 5a). This impression is sup-
ported by analysis of root-to-tip genetic distances for the
best-fit rooted tree, which found an overall trend for
increasing genetic distance with increasing time since a
point in the past (Fig. 5b).
Comparison of the genetic structure of strains from
Scotland and other regions of the UK
We next tested the hypothesis that emm89 strains recovered
in Scotland were a distinct genetic subpopulation compared to
all other emm89 strains from elsewhere in the UK. For this
analysis, we included all emm89 genome data reported in the
Turner et al. manuscript [15] and deposited in publically
available databases. Four strains from Scotland were analysed
in the Turner et al. study, including one each from Dundee,
Glasgow, Edinburgh and Kilmarnock (described in Table S1
Fig. 3. SpeK and Sla encoding prophages. A dot matrix plot compari-
son of SpeK-Sla encoding prophages from Scotland emm89 strain
MGAS31644 and emm2 reference strain MGAS10270 (GenBank acces-
sion number CP000260.1) is shown. The emm89 10270.3-like pro-
phage was partially assembled de novo on two contigs using SPAdes.
The diagonal line indicates portions of the prophages that share 99%
or greater sequence identity over a 50 nucleotide moving window.
High sequence identity is shared over nearly the full-length of the pro-
phages compared.
Fig. 4. Genetic relationships among Scotland throat and invasive isolates. Reconstructed phylogeny of the 122 Scotland strains
inferred by neighbour-joining based on 1410 core SNPs is shown. The tree is rooted on clade 2 reference strain MGAS23530. Strains
are coloured by infection, as indicated in the index. Throat and invasive isolates are intermingled throughout the tree, as groups they
are not separate and genetically distinct.
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of the Turner et al. manuscript). The great majority of the
strains (n=122, 93.1%) were from England localities. Among
the 121 clade 3 organisms from our Scotland sources studied
herein, several genetically distinct phylogenetic branches were
identified (Fig. 1, right). That is, the strains from Scotland
sources do not form a single phylogenetic branch sharing a
large number of identical polymorphisms relative to a most
recent common ancestor. Rather, the clade 3 portion of the
rooted-tree has multiple independent branches of short length
radiating away from a central hub, suggesting that these
strains have evolved fairly randomly away from a relatively
recent common ancestor (Fig. 1, right). In combining all 122
strains from Scotland with all 122 strains from England in
phylogenetic reconstruction (Fig. 6a), strains were intermixed
Fig. 5. Temporal distribution of the Scotland emm89 strains. (a) Reconstructed phylogeny of the 122 Scotland strains inferred by
neighbour-joining based on 1410 core SNPs is shown. Strains are coloured by the year of isolation as indicated in the index. In general,
strains isolated in earlier years are more proximal and in later years are more distal on the tree branches. (b) A scatter plot of root-
to-tip genetic distances for the adjacent 122 Scotland strain tree is shown. The weighted fit shows an overall upward trend and a con-
sistent yearly increase in the root-to-tip distances over 2010–2015.
Fig. 6. Genetic relationships among Scotland and England emm89 strains. (a) Reconstructed phylogeny of 255 emm89 strains inferred
by neighbour-joining based on 2766 Gubbins-filtered core SNPs is shown. Strains are coloured by country, Scotland in blue and
England in red. Consistent with the earlier period of collection of the England strain cohort (ca. 2003–2013) relative to the Scotland
strain cohort (ca. 2010–2016), one-third (41/122) of the England strains are of preepidemic clade 2, whereas only 3 of the 126 Scot-
land strains are clade 2. Moreover, in the epidemic clade 3 portion of the tree (i.e. the right side), by in large the England strains are
more proximal on the branches than the Scotland strains. (b) Reconstructed phylogeny of 89 emm89 strains inferred by neighbour-
joining based on 1087 Gubbins-filtered core SNPs is shown. The 44 Scotland and 43 England strains are temporally matched sets of
all strains collected between 2010–2013.
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independent of country on virtually all branches of the clade 3
side of the tree. This is consistent with the Scotland and
England strains being a single genetic population. Constrain-
ing the reconstruction to only those isolates collected in Scot-
land (n=44) and England (n=43) over the same time period
2010–2013 (Fig. 6b), similarly results in the strains being inter-
mixed independent of country of origin.
DISCUSSION
Our genome sequence data show that with only one
exception, all emm89 isolates recovered in Scotland since
2010 are members of the recently emerged genetic clade
3. These findings add Scotland to the list of countries in
Europe (Finland, Iceland and England) and North Amer-
ica (USA and Canada) where clade 3 emm89 strains have
been documented by full genome sequencing to be
important causes of recent invasive infections and to be
genetically related due to descent from a common
progenitor.
Clade 3 organisms are noteworthy because they have an
evolutionary history involving multiple recent HGT events,
which have contributed to their epidemic emergence [6,
15]. Due to one HGT, emm89 clade 3 strains lack the
hasABC gene region required for synthesis of hyaluronic
acid capsule, as previously reported for GAS emm4 and
emm22 strains [56]. Capsule was long thought to be a crit-
ical S. pyogenes virulence factor by virtue of its antiphago-
cytic properties [57, 58]. Lack of capsule may also affect
virulence by altering GAS adherence interactions [59, 60].
Additionally, emm89 strains have undergone at least two
recent HGT events involving the nga-ifs-slo gene region,
encoding the secreted toxins NADase and streptolysin O
that are documented virulence factors [6, 15]. As a conse-
quence, relative to predecessor clade 1 and clade 2 organ-
isms, clade 3 strains produce an increased amount of these
two important toxins [6, 15, 41]. Upregulation of the nga-
ifs-slo operon and increased production of these two toxins
has been shown to enhance virulence of S. pyogenes in
mouse and non-human primate models of upper respira-
tory tract infection and severe invasive infection [41, 42].
We recently reported that production of both NADase and
SLO are required for full virulence in a mouse infection
model [61]. The loss of capsule production and the
increased production of NADase and SLO may be closely
linked in the emergence of the epidemic clade 3 strains, as
it has been shown that when NGA and SLO are highly
produced, capsule is no longer required for virulence in a
mouse invasive infection model [42].
A further evolution of the emm89 clade 3 clone, via an
additional HGT event involving the spyBA virulence factors
[62, 63] characterized an emergent variant, designated sub-
clade 3D, in bacteremic case isolates from Finland [6, 24].
The subclade 3D strains strongly increased in 2014 as a
cause of bacteremic infections, and have persisted in Fin-
land. Relative to the five other subclades identified among
the bacteremic cases, subclade 3D strains had a
significantly higher 30 day case fatality rate. In assessment
of phylogeny and recombination among the Scotland
emm89 clade 3 strains, no subclade 3D strains were found,
nor were any new HGT events involving other virulence
factors. However, the clear propensity for the GAS emm89
strains to rapidly evolve through HGT recombinational
replacement events generating novel variants of enhanced
virulence warrants continued vigilance in monitoring of
the epidemic clade 3 clone.
Genomic sequencing has revealed differences in MGE con-
tent, phages and ICEs, as the most common source of gene
content differences between GAS strains [64]. GAS phages
commonly encode one or more secreted virulence factors,
such as streptococcal pryogenic exotoxins (spe gene super-
antigens) and streptococcal phage DNases (spd gene exonu-
cleases). GAS ICEs commonly encode one or more
antibiotic resistance factors, usually for macrolides and tet-
racyclines. Small and large outbreaks of GAS infections
have been associated with the acquisition of phages and/or
ICEs. Although no specific ICE was detected in the Scotland
cohort, the tetracycline resistance gene for TetM was
detected in strain MGAS31641. An association with antibi-
otic resistance has not been reported to our knowledge in
any investigation of the current geographically wide spread
increase in emm89 infections. All differences in gene
content between the Scotland strains were attributable to
differences in phage content. Five prophages in nine combi-
nations were found among the 122 Scotland strains (Fig. 2).
The phage content, of the 121 Scotland clade 3 strains, mir-
rored that found for 756 emm89 clade 3 strains of the USA,
Finland and Iceland [6]. The same three prophage geno-
types (PG01, PG02, PG04) in the same ranking were found
most prevalent. Moreover, the same speC and spd1 encoding
phage was found most prevalent among the Scotland and
England emm89 clade 3 strains [15]. The paucity of antibi-
otic resistance and the diversity of prophage profiles found
among the emm89 clade 3 strains in multiple investigations
indicates that no single MGE is conferring a strong selective
advantage in the spread and persistence of the epidemic.
Considerable human flux occurs annually across the rela-
tively short (174 km) border between Scotland and England.
Thus, we anticipated considerable sharing of common
genetic pool of emm89 strains between the two countries.
To test this idea, we compared the SNP-based phylogeny
obtained for this Scotland strain sample with the genome
data published previously by Tuner et al. for the UK [15]
available in public databases. The resultant combined phy-
logeny demonstrated extensive intermixing of the emm89
strains causing infections in these two areas (Fig. 6).
Given the clear recent numerical success of clade 3 organ-
isms in multiple geographically dispersed countries, it is rea-
sonable to speculate that clade 3 strains are present in other
countries that have reported an increase in emm89 disease
activity in recent years. However, full-genome sequence
data are required to confirm this suspicion, since neither
emm gene sequencing nor multi-locus sequence typing
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provide sufficient genetic information to permit clade
identification.
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